Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Evidence of ambiguous differentiation and mTOR pathway dysregulation in subependymal giant cell astrocytoma.

Barrows BD, Rutkowski MJ, Gültekın SH, Parsa AT, Tıhan T.

Turk Patoloji Derg. 2012;28(2):95-103. doi: 10.5146/tjpath.2012.01107.

2.

Role of mTOR signaling pathway in the pathogenesis of subependymal giant cell astrocytoma - A study of 28 cases.

Kumari K, Sharma MC, Kakkar A, Malgulwar PB, Pathak P, Suri V, Sarkar C, Chandra SP, Faruq M, Gupta RK, Saran RK.

Neurol India. 2016 Sep-Oct;64(5):988-94. doi: 10.4103/0028-3886.190274.

3.

WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma.

Rauscher J, Beschorner R, Gierke M, Bisdas S, Braun C, Ebner FH, Schittenhelm J.

J Clin Pathol. 2014 Jul;67(7):556-61. doi: 10.1136/jclinpath-2013-202114. Epub 2014 Mar 7.

PMID:
24607494
4.

Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.

Chan JA, Zhang H, Roberts PS, Jozwiak S, Wieslawa G, Lewin-Kowalik J, Kotulska K, Kwiatkowski DJ.

J Neuropathol Exp Neurol. 2004 Dec;63(12):1236-42.

PMID:
15624760
5.

Subependymal giant cell astrocytoma (SEGA): Is it an astrocytoma? Morphological, immunohistochemical and ultrastructural study.

Buccoliero AM, Franchi A, Castiglione F, Gheri CF, Mussa F, Giordano F, Genitori L, Taddei GL.

Neuropathology. 2009 Feb;29(1):25-30. doi: 10.1111/j.1440-1789.2008.00934.x. Epub 2008 Jun 17.

PMID:
18564101
6.

Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients.

Kotulska K, Borkowska J, Roszkowski M, Mandera M, Daszkiewicz P, Drabik K, Jurkiewicz E, Larysz-Brysz M, Nowak K, Grajkowska W, Domańska-Pakieła D, Jóźwiak S.

Pediatr Neurol. 2014 Apr;50(4):307-12. doi: 10.1016/j.pediatrneurol.2013.12.004. Epub 2013 Dec 10.

PMID:
24507694
7.

IDH1 mutation in pediatric gliomas: has it a diagnostic and prognostic value?

Buccoliero AM, Castiglione F, Degl'Innocenti DR, Gheri CF, Genitori L, Taddei GL.

Fetal Pediatr Pathol. 2012 Oct;31(5):278-82. doi: 10.3109/15513815.2012.659383. Epub 2012 Mar 20.

PMID:
22432788
8.

Diversity of glial cell components in pilocytic astrocytoma.

Tanaka Y, Sasaki A, Ishiuchi S, Nakazato Y.

Neuropathology. 2008 Aug;28(4):399-407. doi: 10.1111/j.1440-1789.2008.00896.x. Epub 2008 Feb 26.

PMID:
18312545
9.

Subependymal giant cell astrocytoma: a lesion with activated mTOR pathway and constant expression of glutamine synthetase.

Buccoliero AM, Caporalini C, Giordano F, Mussa F, Scagnet M, Moscardi S, Baroni G, Genitori L, Taddei GL.

Clin Neuropathol. 2016 Sep-Oct;35(5):295-301. doi: 10.5414/NP300936.

PMID:
27390104
10.

Tuberin and hamartin expression is reduced in the majority of subependymal giant cell astrocytomas in tuberous sclerosis complex consistent with a two-hit model of pathogenesis.

Jóźwiak S, Kwiatkowski D, Kotulska K, Larysz-Brysz M, Lewin-Kowalik J, Grajkowska W, Roszkowski M.

J Child Neurol. 2004 Feb;19(2):102-6.

PMID:
15072102
11.

Comparative analysis of annexin-1 in neuroepithelial tumors shows altered expression with the grade of malignancy but is not associated with survival.

Schittenhelm J, Trautmann K, Tabatabai G, Hermann C, Meyermann R, Beschorner R.

Mod Pathol. 2009 Dec;22(12):1600-11. doi: 10.1038/modpathol.2009.132. Epub 2009 Sep 18.

12.

Diagnostic implications of IDH1-R132H and OLIG2 expression patterns in rare and challenging glioblastoma variants.

Joseph NM, Phillips J, Dahiya S, M Felicella M, Tihan T, Brat DJ, Perry A.

Mod Pathol. 2013 Mar;26(3):315-26. doi: 10.1038/modpathol.2012.173. Epub 2012 Oct 5.

13.

Upregulation of the WNT pathway in tuberous sclerosis-associated subependymal giant cell astrocytomas.

Jozwiak J, Kotulska K, Grajkowska W, Jozwiak S, Zalewski W, Oldak M, Lojek M, Rainko K, Maksym R, Lazarczyk M, Skopinski P, Wlodarski P.

Brain Dev. 2007 Jun;29(5):273-80. Epub 2006 Oct 27.

PMID:
17071037
14.

Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors.

Capper D, Weissert S, Balss J, Habel A, Meyer J, Jäger D, Ackermann U, Tessmer C, Korshunov A, Zentgraf H, Hartmann C, von Deimling A.

Brain Pathol. 2010 Jan;20(1):245-54. doi: 10.1111/j.1750-3639.2009.00352.x. Epub 2009 Oct 27.

PMID:
19903171
15.

BRAF V600E mutation is associated with mTOR signaling activation in glioneuronal tumors.

Prabowo AS, Iyer AM, Veersema TJ, Anink JJ, Schouten-van Meeteren AY, Spliet WG, van Rijen PC, Ferrier CH, Capper D, Thom M, Aronica E.

Brain Pathol. 2014 Jan;24(1):52-66. doi: 10.1111/bpa.12081. Epub 2013 Sep 11.

PMID:
23941441
16.

Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.

Faria MH, Gonçalves BP, do Patrocínio RM, de Moraes-Filho MO, Rabenhorst SH.

Neuropathology. 2006 Dec;26(6):519-27.

PMID:
17203587
17.

Pathological Findings of a Subependymal Giant Cell Astrocytoma Following Treatment With Rapamycin.

Cheng S, Hawkins C, Taylor MD, Bartels U.

Pediatr Neurol. 2015 Sep;53(3):238-242.e1. doi: 10.1016/j.pediatrneurol.2015.05.020. Epub 2015 Jun 14.

PMID:
26173783
18.

Adult grade II diffuse astrocytomas are genetically distinct from and more aggressive than their paediatric counterparts.

Jones DT, Mulholland SA, Pearson DM, Malley DS, Openshaw SW, Lambert SR, Liu L, Bäcklund LM, Ichimura K, Collins VP.

Acta Neuropathol. 2011 Jun;121(6):753-61. doi: 10.1007/s00401-011-0810-6. Epub 2011 Feb 17.

PMID:
21327941
19.

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A, Felsberg J, Wolter M, Mawrin C, Wick W, Weller M, Herold-Mende C, Unterberg A, Jeuken JW, Wesseling P, Reifenberger G, von Deimling A.

Acta Neuropathol. 2009 Oct;118(4):469-74. doi: 10.1007/s00401-009-0561-9. Epub 2009 Jun 25.

PMID:
19554337
20.

Phosphorylation profiles of protein kinases in alveolar and embryonal rhabdomyosarcoma.

Cen L, Arnoczky KJ, Hsieh FC, Lin HJ, Qualman SJ, Yu S, Xiang H, Lin J.

Mod Pathol. 2007 Sep;20(9):936-46. Epub 2007 Jun 22.

Supplemental Content

Support Center